CTOs on the Move

FLAEM NUOVA S.P.A

www.flaemnuova.com

 
FLAEM NUOVA S.P.A is a North Reading, MA-based company in the Manufacturing sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

cooper b-lines

cooper b-lines is a Highland, IL-based company in the Manufacturing sector.

Fortive

Fortive is a global family of more than 20 industry-leading industrial growth and technology companies, united by a shared purpose: to make the world stronger, safer and more effective by providing essential technology for the people who accelerate progress. We take on big challenges that have real impact in fast-moving fields like software development, robotics, transportation, energy and healthcare. We have an outstanding heritage, created from Danaher, and launched our new company, Fortive, in 2016. Here, the excitement of a “startup” balances with the stability of an organization grounded in its roots and with a proven track record of growth. This foundation of success and our financial strength provide Fortive and our employees extraordinary opportunities for growth and innovation. There`s no limit to what you can learn, or the impact you can make. We are a vibrant culture defined by opportunity, empowerment and continuous learning and growth. We are an extraordinary team, working together to achieve extraordinary things.

Surgical Solutions Inc

Surgical Solutions Inc is a Ann Arbor, MI-based company in the Manufacturing sector.

Tankheads Inc

Tankheads Inc is a Haslet, TX-based company in the Manufacturing sector.

Digital Diagnostics

Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare.